Clinical Trial Update: Fondaparinux EU-RMP (Adherence)

View source ↗

Summary

A completed clinical trial update evaluating adherence to the Fondaparinux EU risk management plan in patients with Acute Coronary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acute Coronary Syndrome | Status: COMPLETED